Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1985 1
1989 1
1992 1
1994 1
1997 1
1998 2
2001 3
2002 7
2003 7
2004 11
2005 13
2006 21
2007 31
2008 32
2009 44
2010 67
2011 57
2012 65
2013 82
2014 111
2015 147
2016 145
2017 176
2018 185
2019 260
2020 305
2021 329
2022 295
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

2,143 results
Results by year
Filters applied: . Clear all
Page 1
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study.
Xu J, Shen L, Bai C, Wang W, Li J, Yu X, Li Z, Li E, Yuan X, Chi Y, Yin Y, Lou W, Xu N, Bai Y, Zhang T, Xiu D, Wang X, Yuan Y, Chen J, Qin S, Jia R, Lu M, Cheng Y, Zhou Z, Li J, He J, Su W. Xu J, et al. Among authors: jia r. Lancet Oncol. 2020 Nov;21(11):1489-1499. doi: 10.1016/S1470-2045(20)30493-9. Epub 2020 Sep 20. Lancet Oncol. 2020. PMID: 32966810 Clinical Trial.
2,143 results